THIS IS HUGE

Time to Get $HUGE While it’s Trading Under $0.50

Charts and upcoming catalysts suggest a “positive” momentum move for this (NASDAQ:HUGE) for this Penny Stock that everyone can afford to buy.

Trading signals are beginning to show that this oversold stock, FSD Pharma (NASDAQ:HUGE), has begun the “accumulation” phase, just as the Russell 2000 small-cap stocks ETF (Ticker: IWM) call option volume spiked to its highest ever levels.
This level of call option volume is almost always proof that in-the-know insiders, the Pelosi types, know that a significant upside move is just around the corner.
$HUGE’s chart appears to confirm, as increasing daily volume indicates, that the recent sell-off has subsided and it’s now poised for a huge breakout, driven by a powerful expected catalyst.
Many low-priced stocks have been experiencing a trading renaissance this summer, as we have covered multiple stocks with similar structures and catalysts that surged significantly higher creating substantial gains for traders.
(NASDAQ:HUGE) could be the next low priced red to green reversal play that triggers a stampede of buyers running to get cheap shares before it surges 100% or more.
They have a new product, called UNBUZZD™, which is being unveiled as a revolutionary rapid alcohol detoxification drink.
In other words, it helps to rapidly restore mental alertness post-alcohol consumption. The best part is FSD teamed up with the top industry vets to bring this product to market and success tends to breed success, so expectations could not be higher.
The company’s stock has been trending sideways, for the last month, and beginning to inch up, on increasing volume, so it’s time to pick some of this up before potential catalysts send it much higher.
The risk reward ratio here is very appealing, risking 10% to possibly make 100%, according to the current support and resistance levels, and that’s just for the first wave, as HUGE hasn’t traded below $0.13, while the drop from its 52-week high was on fairly small volume.

Recent winners similar to $HUGE

(NASDAQ:MBIO) Mustang Bio hit the summer running from $0.12 to a high of $1.25 and traded more than 1 BILLION shares!

(NASDAQ:FFIE) was another that jumped from .03 to a high of more than $3, as it squeezed higher and higher.

(NASDAQ:KZIA) Kazia Therapeutics ran from .30 to a high of $1.58, giving traders several opportunities to make more than 100%.

(NASDAQ:VRPX) busted out from .46 to over $3, in just a few days.

(NASDAQ:OPTT) was trading around .12 and hit a high of .57 while setting its new volume record, over 600 million shares, on July 2nd.

(NASDAQ:LUCY) quickly ripped on its reversal from .16 to over $1.36.

We covered these and many others with similar structures and expected breaking news catalysts. If you missed these stocks, you won’t want to miss $HUGE.

FSD Pharma is turning around more than just its market. It replaced its old CEO and focused on developing promising new technologies, which takes time and expertise, and explains the share price, but $HUGE recently won a multimillion-dollar judgement against the old management and is now focused on creating real shareholder value.

$HUGE is heading in a new direction with an all-star team:

As the UNBUZZD™, HUGE’s new nutraceutical product, project began to grow, its appeal was so obvious that it attracted the best minds in this space, like legendary Shark Tank investor, Kevn Harrington.

UNBUZZD™ is slated to be available in the near future, as HUGE brought in the team responsible for launching the Celsius Brand (NASDAQ:CELH), signed an agreement with Celly Nu, ac.

Gerry David, the Former CEO of Celsius™

The team is led by the CEO Gerry David, who helmed the Celsius energy drink company during its meteoric 35-fold increase in shareholder value exceeding $9 billion in market cap and more than $1 billion in sales.

Kevin Harrington, the Marketing Guru

While Harrington, the Shark who created the infomercial, helped develop the Celsius Influencer marketing program.

John Duffy Jr.

John Duffy, who worked with Coca Cola for more than 22 years, managed Coke’s Sysco Food Systems distribution team.

"HUGE expects to receive a 7% royalty on UNBUZZD™ sales up to $250 million and then 3% from that point forward, with FSD retaining a 25% stake in Celly Nu until it reaches a $1 Billion market cap."

Surely, even Mr Wonderful is jealous of this deal structure.​

FSD also encompassed blood tests resulting in lowering blood alcohol levels.

Proceeds from FSD’s loan to Celly Nu will be used towards UNBUZZD™ product manufacturing which will be released later this summer. UNBUZZD™ is Celly Nutrition’s innovative contribution to the wellness and recovery supplement market. This scientifically formulated blend of vitamins, minerals, and herbs is engineered to enhance mental alertness, expedite alcohol metabolism, and facilitate rapid recovery from alcohol consumption, empowering individuals to “own now and what’s next”.

Nutraceuticals are big business, but a powder or vitamin that can help you get sober after a night of drinking should be worth a lot of money, as US alcohol sales eclipsed $260 billion, just in 2022.
The festivities result in an annual arrest rate of more than 1.5 million DWI arrests in the US.

Not to mention the cost of a DWI is north of $20,000.

HUGE has a $5.5 million market cap today, a relatively small float of less than 40 million shares, and had 30 million shares in the float when the stock was trading above $2, a couple years ago.
FSD or $HUGE has also indicated they may do a share consolidation re-structuring, soon, to better represent its current business identity and branding. This would allow for a massive reverse split trade run up.
The stars are aligned for $HUGE to become, well $HUGE, simply via a niche product that millions of people can tap on a regular basis worldwide. They have the right team and all that’s left to do is sit back and let them work their magic.
This should be an easy trade up to $0.50, or even higher on any news of the products hitting the shelves.

Take advantage of opportunities for profits, don’t get greedy and don’t keep holding if it breaks below you Stop.

Chief Editor.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.